MicroRNA-100 regulates IGF1-receptor expression in metastatic pancreatic cancer cells

Biotechnic and Histochemistry

Volumn 88, Issue 7, 2013, Pages 397-402

  Huang, Js ^a   Egger, Me ^a   Grizzle, We ^b   McNally, Lr ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

IGF1 receptor; Metastasis; MicroRNA 100; MicroRNA 138; Pancreatic cancer

Indexed keywords

MESSENGER RNA; MICRORNA; SOMATOMEDIN C RECEPTOR;

CONFERENCE PAPER; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; RECEPTOR, IGF TYPE 1; RNA, MESSENGER;

EID: 84884391106     PISSN: 10520295     EISSN: 14737760     Source Type: Journal    
DOI: 10.3109/10520295.2012.762460     Document Type: Conference Paper

References (33)

1. Amm HM, Zhou T, Steg AD, Kuo H, Li Y, Buchsbaum DJ (2011) Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells. Mol. Cancer Res. 9:403-417.
2. Baserga R, Peruzzi F, Reiss K (2003a) The IGF-1 receptor in cancer biology. Int. J. Cancer 107:873-877. (Pubitemid 37429826)
3. Baserga R, Prisco M, Yuan T (2003b) IGF-1 Receptor Signaling in Health and Disease. Landes Bioscience, Georgetown, TX. pp. 120-140.
4. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E, Spector Y, Bentwich Z (2005) Identification of hundreds of conserved and nonconserved human microRNAs. Nat. Genet. 37:766-770. (Pubitemid 41754896)
5. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat. Rev. Cancer 6:857-866. (Pubitemid 44629897)
6. Chambers AF, Groom AC, MacDonald IC (2002) Metastasis:dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2:563-572. (Pubitemid 37328923)
7. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M (1998) Plasma insulin-like growth factor-I and prostate cancer risk:A prospective study. Science 279:563-566. (Pubitemid 28067285)
8. Chung EJ, Brown AP, Asano H, Mandler M, Burgan WE, Carter D, Camphausen K, Citrin D (2009) In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase. Clin. Cancer Res. 15:3050-3057.
9. Couch FJ, Johnson MR, Rabe KG, Brune K, Andrade M, Goggins M, Rothenmund H, Gallinger S, Klein A, Petersen GM, Hruban RH (2007) The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol. Biomarkers Prev. 16:342-346. (Pubitemid 46383356)
10. Esquela-Kerscher A, Slack FJ (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6:259-269.
11. Grundmann S, Hans FP, Kinniry S, Heinke J, Helbing T, Bluhm F, Sluijter JP, Hoefer I, Pasterkamp G, Bode C, Moser M (2011) MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells. Circulation 123:999-1009.
12. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396. (Pubitemid 28209997)
13. Jaquish DV, Yu PT, Shields DJ, French RP, Maruyama KP, Niessen S, Hoover H, A Cheresh D, Cravatt B, Lowy AM (2011) IGF1-R signals through the RON receptor to mediate pancreatic cancer cell migration. Carcinogenesis 32:1151-1156.
14. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics. Cancer J. Clin. 58:71-96.
15. Jiang L, Dai Y, Liu X, Wang C, Wang A, Chen Z, Heidbreder CE, Kolokythas A, Zhou X (2011) Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma. Hum. Genet. 129:189-197.
16. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, Lin C, Socci ND, Hermida L, Fulci V, Chiaretti S, Foa R, Schliwka J, Fuchs U, Novosel A, Muller RU, Schermer B, Bissels U, Inman J, Phan Q, Chien M, Weir DB, Choksi R, Vita GD, Frezzetti D, Trompeter HI, Hornung V, Teng G, Hartmann G, Palkovits M, Lauro RD, Wernet P, Macino G, Rogler CE, Nagle JW, Ju J, Papavasiliou FN, Benzing T, Lichter P, Tam W, Brownstein MJ, Bosio A, Borkhardt A, Russo JJ, Sander C, Zavolan M, Tuschl T (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129:1401-1414. (Pubitemid 46970709)
17. Leite KRM, Tomiyama A, Reis ST, Sousa-Canavez JM, Sanudo A, Dall'Oglio MF, Camara-Lopes LH (2011) Micro-RNA-100 expression is independently related to biochemical recurrence of prostate cancer. J. Urol. 183:1118-1122.
18. Li D, Xie K, Wolff R, Abbruzzese JL (2004) Pancreatic cancer. Lancet 363:1049-1057. (Pubitemid 38410779)
19. Li J, Kleeff J, Guo J, Fischer L, Giese N, Bü chler MW, Friess H (2003) Effects of STI571 (gleevec) on pancreatic cancer cell growth. Molec. Cancer 2:32.
20. Liu X, Jiang L, Wang A, Yu J, Shi F, Zhou X (2009) Micro-RNA-138 suppresses invasion and promotes apoptosis in head and neck squamous cell carcinoma cell lines. Cancer Lett. 286:217-222.
21. Liu X, Wang C, Chen Z, Jin Y, Wang Y, Kolokythas A, Dai Y, Zhou X (2011) MicroRNA-138 suppresses epithelial-mesenchymal transition in squamous cell carcinoma cell lines. Biochem. J. 440:23-31.
22. Lopez T, Hanahan D (2002) Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 1:339-353. (Pubitemid 41039136)
23. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst. 91:620-625. (Pubitemid 29194048)
24. Mauro L, Salerno ME, Morelli C, Roterberg T, Bracke ME, Surmacz E (2002) Role of the IGF-1 receptor in the regulation of cell-cell adhesion:implications in cancer development and progression. J. Cell. Physiol. 94:108-116.
25. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, Mclntyre DH, Madhu B, Goldgraben MA, Caldwell ME, Allard D, Frese KK, DeNicola G, Feig C, Combs C, Winter SP, Ireland-Zecchini H, Reichelt S, Howat WJ, Chang A, Dhara M, Wang L, Ruckert F, Grutzmann R, Pilarsky C, Izeradjene K, Hingorani SR, Huang P, Davies SE, Plunkett W, Egorin M, Hruban RH, Whitebread N, McGovern K, Adams J, Iacobuzio-Donahue C, Griffiths J, Tuveson DA (2009) Inhibition of hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324:1457-1461.
26. Oliveira JC, Brassesco MS, Morales AG, Pezuk JA, Fedatto PF, Silva GN, Scrideli CA, Tone LG (2011) MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells. Asian Pacific J. Cancer Prev. 1 2:3 001-3 004.
27. Ouban A, Muraca P, Yeatman T, Coppola D (2003) Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. Hum. Pathol. 34:803-808. (Pubitemid 37040618)
28. Peng DX, Luo M, Qiu LW, He YL, Wang XF (2012) Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer. Oncol. Rep. 27:1238-1244.
29. Rajeshkumar NV, Tan AC, De Oliveira E, Womack C, Wombwell H, Morgan S, Warren MV, Walker J, Green TP, Jimeno A, Messersmith WA, Hidalgo M (2009) Antitumor effects and biomarkers of activity of AZD0530, a Src inhibitor, in pancreatic cancer. Clin. Cancer Res. 15:4138-4146.
30. Sekharam M, Zhao H, Sun M, Fang Q, Zhang Q, Yuan Z, Dan HC, Boulware D, Cheng JQ, Coppola D (2003) Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway. Cancer Res. 63:7708-7716. (Pubitemid 37466701)
31. Taromaru GC, DE Oliveira VM, Silva MA, Montor WR, Bagnoli F, Rinaldi JF, Aoki T (2012) Interaction between cyclooxygenase-2 and insulin-like growth factor in breast cancer:a new field for prevention and treatment. Oncol. Lett. 3:682-688.
32. Wente MN, Jain A, Kono E, Berberat PO, Giese T, Reber HA, Friess H, Buchler MW, Reiter RE, Hines OJ (2005) Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer. Pancreas 31:119-125. (Pubitemid 41077139)
33. Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X (1999) Plasma levels of insulin-like growth factor-I and lung cancer risk:a case-control analysis. J. Natl. Cancer Inst. 91:151-156. (Pubitemid 29042692)